We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$79.7B
AUM Growth
+$3.42B
Cap. Flow
-$854M
Cap. Flow %
-1.07%
Top 10 Hldgs %
14.29%
Holding
1,817
New
122
Increased
851
Reduced
711
Closed
96

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$281M
2
CMCSA icon
Comcast
CMCSA
+$235M
3
AAPL icon
Apple
AAPL
+$172M
4
MET icon
MetLife
MET
+$151M
5
MAA icon
Mid-America Apartment Communities
MAA
+$148M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$399M
2
UBS icon
UBS Group
UBS
+$393M
3
TV icon
Televisa
TV
+$305M
4
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
+$278M
5
EDU icon
New Oriental
EDU
+$169M

Sector Composition

Rank Sector Weight
1 Energy 15.42%
2 Financials 13.04%
3 Healthcare 11.98%
4 Consumer Discretionary 11.9%
5 Technology 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
26
Microsoft
MSFT
$2.86T
$502M 0.63%
8,723,403
+1,596,878
+22% +$90.1M
AMZN icon
27
Amazon
AMZN
$2.52T
$497M 0.62%
11,868,120
+1,337,900
+13% +$51.2M
EPD icon
28
Enterprise Products Partners
EPD
$84B
$486M 0.61%
17,596,553
-297,497
-2% -$8.22M
ETP
29
DELISTED
Energy Transfer Partners, L.P.
ETP
$481M 0.6%
16,939,419
-853,638
-5% -$24.8M
MRK icon
30
Merck
MRK
$324B
$467M 0.59%
7,845,353
+86,158
+1% +$5.04M
LVS icon
31
Las Vegas Sands
LVS
$30.1B
$457M 0.57%
7,946,720
+145,820
+2% +$7.52M
JNJ icon
32
Johnson & Johnson
JNJ
$632B
$454M 0.57%
3,841,787
-1,143,929
-23% -$139M
NKTR icon
33
Nektar Therapeutics
NKTR
$2.39B
$430M 0.54%
1,666,974
-66,716
-4% -$17.2M
PM icon
34
Philip Morris
PM
$301B
$429M 0.54%
4,417,339
-241,314
-5% -$24.2M
CCL icon
35
Carnival Corporation Ltd
CCL
$35.6B
$426M 0.53%
8,717,222
-662,720
-7% -$30.7M
MPLX icon
36
MPLX
MPLX
$58.8B
$420M 0.53%
12,409,717
+696,774
+6% +$23M
MDLZ icon
37
Mondelez International
MDLZ
$77.5B
$420M 0.53%
9,567,444
+245,263
+3% +$10.8M
JPM icon
38
JPMorgan Chase
JPM
$927B
$417M 0.52%
6,268,431
-745,609
-11% -$48.6M
BIIB icon
39
Biogen
BIIB
$29.8B
$417M 0.52%
1,330,963
+6,562
+0.5% +$1.94M
TIF
40
DELISTED
Tiffany & Co.
TIF
$415M 0.52%
5,718,156
+1,452,356
+34% +$96.9M
CME icon
41
CME Group
CME
$91.7B
$410M 0.51%
3,922,756
-948,193
-19% -$99M
INTU icon
42
Intuit
INTU
$80.1B
$404M 0.51%
3,674,036
+32,674
+0.9% +$3.65M
ET icon
43
Energy Transfer Partners
ET
$70.3B
$402M 0.51%
23,964,238
+737,226
+3% +$12.4M
IBN icon
44
ICICI Bank
IBN
$106B
$382M 0.48%
56,199,935
+7,898
+0% +$55K
BRK.B icon
45
Berkshire Hathaway Class B
BRK.B
$1.06T
$378M 0.48%
2,619,159
+27,299
+1% +$3.99M
VZ icon
46
Verizon
VZ
$188B
$376M 0.47%
7,224,335
-607,073
-8% -$32.6M
MXIM
47
DELISTED
Maxim Integrated Products
MXIM
$374M 0.47%
9,364,788
-145,610
-2% -$5.74M
JCI icon
48
Johnson Controls International
JCI
$87.4B
$364M 0.46%
7,817,555
+6,056,201
+344% +$281M
ZBH icon
49
Zimmer Biomet
ZBH
$17.7B
$359M 0.45%
2,841,628
+156,407
+6% +$19.3M
AVAL icon
50
Grupo Aval
AVAL
$5.82B
$356M 0.45%
40,328,273
+659,234
+2% +$5.41M
1
2
3 4 5

Similar funds

TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
SBAM
Santa Barbara Asset Management Los Angeles, California $6.43B AUM 10.99% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
SA
SQ Advisors Naples, Florida $1.32B AUM 10.3% 1-Year Est. Return
WF
WealthTrust Fairport Cleveland, Ohio $1.06B AUM 3.47% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

OppenheimerFunds's Q3 2016 Portfolio in Review

As of Q3 2016, OppenheimerFunds held 1,817 positions worth $79.7B, up 4.5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

OppenheimerFunds's Q3 2016 filing shows 122 new, 851 increased, 711 reduced and 96 closed positions. Its largest new stake was Fomento Económico Mexicano: 1,462,419 shares worth $135M. The largest sale was Bristol-Myers Squibb, an estimated $399M.

By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • OppenheimerFunds's largest Q3 2016 buy was Fomento Económico Mexicano: 1,462,419 shares worth $135M.
  • OppenheimerFunds added most to Johnson Controls International in Q3 2016, an estimated $281M increase.
  • OppenheimerFunds's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $399M.
  • OppenheimerFunds fully exited UBS Group in Q3 2016, selling an estimated $393M.
  • OppenheimerFunds's ten largest holdings make up 14% of its $79.7B portfolio in Q3 2016.
  • OppenheimerFunds opened 122 new positions and closed 96 in Q3 2016.
  • OppenheimerFunds's portfolio value rose 4.5% quarter-over-quarter to $79.7B.

Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.